Insider Selling: Cipher Pharmaceuticals Inc. (TSE:CPH) Director Sells 3,500 Shares of Stock

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of the stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total value of C$47,215.00.

Cipher Pharmaceuticals Stock Down 3.3 %

Shares of CPH traded down C$0.44 during mid-day trading on Monday, hitting C$12.70. 18,709 shares of the company traded hands, compared to its average volume of 36,476. The company has a market capitalization of C$228.01 million, a PE ratio of 14.03 and a beta of 1.20. The company has a quick ratio of 2.67, a current ratio of 2.00 and a debt-to-equity ratio of 41.22. The business has a 50 day moving average of C$12.91 and a 200 day moving average of C$14.46. Cipher Pharmaceuticals Inc. has a 1-year low of C$7.90 and a 1-year high of C$19.69.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.